13F

Stock

Enliven Therapeutics, Inc.

ELVN · held by 2 managers

Reported value

$14.2M

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$142K

Price effect on 1 books still in the name

Largest holder

$13.2M

Boxer Capital Management, LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Boxer Capital Management, LLC671.4K$13.2MHeld
BARCLAYS PLC50.4K$991K−$142KCut−$461.6K

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.